Literature DB >> 29760533

Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen.

Tim Rollenske1,2, Valeria Szijarto3, Jolanta Lukasiewicz4, Luis M Guachalla3, Katarina Stojkovic4, Katharina Hartl3, Lukas Stulik3, Simone Kocher2, Felix Lasitschka5, Mohammed Al-Saeedi6, Jutta Schröder-Braunstein7, Moritz von Frankenberg8, Gereon Gaebelein9,10, Peter Hoffmann11, Sabrina Klein12, Klaus Heeg12, Eszter Nagy3, Gabor Nagy3, Hedda Wardemann13,14.   

Abstract

Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29760533     DOI: 10.1038/s41590-018-0106-2

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  43 in total

Review 1.  Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.

Authors:  Dani A C Heesterbeek; Mathieu L Angelier; Richard A Harrison; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2018-08-27       Impact factor: 7.349

Review 2.  IgA Responses to Microbiota.

Authors:  Jeffrey J Bunker; Albert Bendelac
Journal:  Immunity       Date:  2018-08-21       Impact factor: 31.745

Review 3.  Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA.

Authors:  Kang Chen; Giuliana Magri; Emilie K Grasset; Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2020-02-03       Impact factor: 53.106

Review 4.  IgM memory B cells: specific effectors of innate-like and adaptive responses.

Authors:  Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Curr Opin Immunol       Date:  2019-10-19       Impact factor: 7.486

5.  Microbial metabolism of L-tyrosine protects against allergic airway inflammation.

Authors:  Tomasz P Wypych; Céline Pattaroni; Olaf Perdijk; Carmen Yap; Aurélien Trompette; Dovile Anderson; Darren J Creek; Nicola L Harris; Benjamin J Marsland
Journal:  Nat Immunol       Date:  2021-01-25       Impact factor: 25.606

Review 6.  Monoclonal antibody-based therapies for bacterial infections.

Authors:  Michael P Motley; Kasturi Banerjee; Bettina C Fries
Journal:  Curr Opin Infect Dis       Date:  2019-06       Impact factor: 4.915

7.  On-chip stool liquefaction via acoustofluidics.

Authors:  Shuaiguo Zhao; Weihua He; Zhehan Ma; Peiyao Liu; Po-Hsun Huang; Hunter Bachman; Lin Wang; Shujie Yang; Zhenhua Tian; Zeyu Wang; Yuyang Gu; Zhemiao Xie; Tony Jun Huang
Journal:  Lab Chip       Date:  2019-03-13       Impact factor: 6.799

8.  Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis.

Authors:  Anne-Katrin Pröbstel; Xiaoyuan Zhou; Ryan Baumann; Sven Wischnewski; Michael Kutza; Olga L Rojas; Katrin Sellrie; Antje Bischof; Kicheol Kim; Akshaya Ramesh; Ravi Dandekar; Ariele L Greenfield; Ryan D Schubert; Jordan E Bisanz; Stephanie Vistnes; Khashayar Khaleghi; James Landefeld; Gina Kirkish; Friederike Liesche-Starnecker; Valeria Ramaglia; Sneha Singh; Edwina B Tran; Patrick Barba; Kelsey Zorn; Johanna Oechtering; Karin Forsberg; Lawrence R Shiow; Roland G Henry; Jennifer Graves; Bruce A C Cree; Stephen L Hauser; Jens Kuhle; Jeffrey M Gelfand; Peter M Andersen; Jürgen Schlegel; Peter J Turnbaugh; Peter H Seeberger; Jennifer L Gommerman; Michael R Wilson; Lucas Schirmer; Sergio E Baranzini
Journal:  Sci Immunol       Date:  2020-11-20

9.  A bifunctional O-antigen polymerase structure reveals a new glycosyltransferase family.

Authors:  Bradley R Clarke; Olga G Ovchinnikova; Ryan P Sweeney; Evelyn R Kamski-Hennekam; Russel Gitalis; Evan Mallette; Steven D Kelly; Todd L Lowary; Matthew S Kimber; Chris Whitfield
Journal:  Nat Chem Biol       Date:  2020-03-09       Impact factor: 15.040

10.  Antibiotic therapy-induced collateral damage: IgA takes center stage in pulmonary host defense.

Authors:  Juergen Lohmeyer; Rory E Morty; Susanne Herold
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.